Table 2 Patients’ characteristics
Characteristics | Number of patients (n = 47) |
|---|---|
Age (years), mean ± SD [min-max] | 56.1 ± 12.3 [29–80] |
Histologic type, n (%) | |
Ductal | 38 (80.8) |
Lobular | 2 (4.3) |
Mixed type | 5 (10.6) |
Others | 2 (4.3) |
Estrogen receptor status, n (%) | |
Positive | 40 (85.1) |
Negative | 7 (14.9) |
Progesterone receptor status, n (%) | |
Positive | 33 (70.2) |
Negative | 14 (29.8) |
HER2 status | |
Positive | 6 (12.8) |
Negative | 41 (87.2) |
Mitotic grade | |
1–2 | 29 (61.7) |
3 | 18 (38.3) |
T, n (%) | |
T1 | 13 (27.6) |
T2 | 24 (51.1) |
T3 | 10 (21.3) |
N, n (%) | |
0 | 14 (29.8) |
1 | 24 (51.1) |
2 | 5 (10.6) |
3 | 4 (8.5) |
AJCC stage, n (%) | |
I | 4 (8.5) |
IIA | 16 (34.0) |
IIB | 11 (23.4) |
IIIA | 12 (25.6) |
IIIB | 0 (0) |
IIIC | 4 (8.5) |